Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
Aims are to inform product development with a discrete choice experiment (DCE) to identify product preferences and identify patient characteristics associated with acceptability among 200 ART naïve-individuals and 500 ART-experienced individuals in Seattle and Atlanta and then in Nairobi (N=700).
Countries
Active Dates
07/01/2019 to 06/30/2024
Faculty Involved
Organizations
Health Topics